Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity

Int J Mol Sci. 2024 Jan 4;25(1):673. doi: 10.3390/ijms25010673.

Abstract

The inflammatory bowel disease (IBD) is associated with gut microbiota dysbiosis; however, studies on methanogens-especially those focused on children-are extremely limited. The aim of this study was to determine the abundance of total methanogenic archaea and their three subgroups: Methanobrevibacter (Mb.) smithii, Methanosphaera (Ms.) stadtmanae, and Methanomassiliicoccales, in the feces of children with both active and inactive Crohn's disease (CD) and ulcerative colitis (UC). The results of a quantitative real-time PCR were cross-referenced with the disease type (CD vs. UC) and activity assessed with the use of Pediatric Crohn's Disease Activity Index (PCDAI) and Pediatric Ulcerative Colitis Activity Index (PUCAI) indices, and fecal calprotectin (FCP) concentration, and compared with controls. There was a significant decrease in the number of total methanogens in CD and UC compared to controls. The prevalence of total methanogens was also lower in UC compared to controls. Furthermore, patients from the inactive UC group were colonized by a lower number of Mb. smithii, and demonstrated the most pronounced positive correlation between the number of Ms. stadtmanae and the FCP concentration. Our results demonstrate that gut methanogens are related to the type and activity of pediatric IBD.

Keywords: Crohn’s disease; archaea; children; fecal calprotectin; inflammatory bowel disease; methanogens; ulcerative colitis.

MeSH terms

  • Archaea / genetics
  • Child
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Euryarchaeota*
  • Humans
  • Inflammatory Bowel Diseases*
  • Leukocyte L1 Antigen Complex

Substances

  • Leukocyte L1 Antigen Complex